AAAAAA

   
Results: 1-10 |
Results: 10
T-CELL-TARGETED IMMUNOFUSION PROTEINS FROM ESCHERICHIA-COLI
Authors: BETTER M BERNHARD SL WILLIAMS RE LEIGH SD BAUER RJ KUNG AHC CARROLL SF FISHWILD DM
Citation: M. Better et al., T-CELL-TARGETED IMMUNOFUSION PROTEINS FROM ESCHERICHIA-COLI, The Journal of biological chemistry, 270(25), 1995, pp. 14951-14957
CYSTEINE ANALOGS OF RECOMBINANT BARLEY RIBOSOME-INACTIVATING PROTEIN FORM ANTIBODY CONJUGATES WITH ENHANCED STABILITY AND POTENCY IN-VITRO
Authors: BERNHARD SL BETTER M FISHWILD DM LANE JA ORME AE GARRISON DA BIRR CA LEI SP CARROLL SF
Citation: Sl. Bernhard et al., CYSTEINE ANALOGS OF RECOMBINANT BARLEY RIBOSOME-INACTIVATING PROTEIN FORM ANTIBODY CONJUGATES WITH ENHANCED STABILITY AND POTENCY IN-VITRO, Bioconjugate chemistry, 5(2), 1994, pp. 126-132
T-CELL-TARGETED IMMUNOFUSION PROTEINS FROM ESCHERICHIA-COLI
Authors: BETTER M NOLAN P GAVIT P FISHWILD D WU HM BERNHARD S SOARES S MORALES W
Citation: M. Better et al., T-CELL-TARGETED IMMUNOFUSION PROTEINS FROM ESCHERICHIA-COLI, Journal of cellular biochemistry, 1994, pp. 186-186
HUMAN-ENGINEERED MONOCLONAL-ANTIBODIES RETAIN FULL SPECIFIC BINDING-ACTIVITY BY PRESERVING NON-CDR COMPLEMENTARITY-MODULATING RESIDUES
Authors: STUDNICKA GM SOARES S BETTER M WILLIAMS RE NADELL R HORWITZ AH
Citation: Gm. Studnicka et al., HUMAN-ENGINEERED MONOCLONAL-ANTIBODIES RETAIN FULL SPECIFIC BINDING-ACTIVITY BY PRESERVING NON-CDR COMPLEMENTARITY-MODULATING RESIDUES, Protein engineering, 7(6), 1994, pp. 805-814
CHIMERIC IMMUNOGLOBULIN LIGHT-CHAINS ARE SECRETED AT DIFFERENT LEVELS- INFLUENCE OF FRAMEWORK-1 AMINO-ACIDS
Authors: HORWITZ AH NADELL R PREUGSCHAT F BETTER M
Citation: Ah. Horwitz et al., CHIMERIC IMMUNOGLOBULIN LIGHT-CHAINS ARE SECRETED AT DIFFERENT LEVELS- INFLUENCE OF FRAMEWORK-1 AMINO-ACIDS, Molecular immunology, 31(9), 1994, pp. 683-692
GELONIN ANALOGS WITH ENGINEERED CYSTEINE RESIDUES FORM ANTIBODY IMMUNOCONJUGATES WITH UNIQUE PROPERTIES
Authors: BETTER M BERNHARD SL FISHWILD DM NOLAN PA BAUER RJ KUNG AHC CARROLL SF
Citation: M. Better et al., GELONIN ANALOGS WITH ENGINEERED CYSTEINE RESIDUES FORM ANTIBODY IMMUNOCONJUGATES WITH UNIQUE PROPERTIES, The Journal of biological chemistry, 269(13), 1994, pp. 9644-9650
CLONING AND EXPRESSION OF A GENE ENCODING GELONIN, A RIBOSOME-INACTIVATING PROTEIN FROM GELONIUM-MULTIFLORUM
Authors: NOLAN PA GARRISON DA BETTER M
Citation: Pa. Nolan et al., CLONING AND EXPRESSION OF A GENE ENCODING GELONIN, A RIBOSOME-INACTIVATING PROTEIN FROM GELONIUM-MULTIFLORUM, Gene, 134(2), 1993, pp. 223-227
EFFICACY OF ANTI-CD5 F(AB')2 AND FAB' IMMUNOCONJUGATES IN HUMAN PERIPHERAL-BLOOD LYMPHOCYTE-RECONSTITUTED SEVERE COMBINED IMMUNODEFICIENT MICE
Authors: KOHN FR FISHWILD DM BERNHARD SL BETTER M KUNG AHC
Citation: Fr. Kohn et al., EFFICACY OF ANTI-CD5 F(AB')2 AND FAB' IMMUNOCONJUGATES IN HUMAN PERIPHERAL-BLOOD LYMPHOCYTE-RECONSTITUTED SEVERE COMBINED IMMUNODEFICIENT MICE, International journal of immunopharmacology, 15(8), 1993, pp. 871-878
ENGINEERING THE BULLET - ANTIBODIES AND BACTERIA
Authors: BETTER M WEICKMANN J
Citation: M. Better et J. Weickmann, ENGINEERING THE BULLET - ANTIBODIES AND BACTERIA, Chemtech, 23(5), 1993, pp. 14-20
ENGINEERED ANTIBODIES AND ANTIBODY FRAGMENTS FOR HUMAN-DISEASE MANAGEMENT
Authors: BETTER M THEOFAN G
Citation: M. Better et G. Theofan, ENGINEERED ANTIBODIES AND ANTIBODY FRAGMENTS FOR HUMAN-DISEASE MANAGEMENT, Journal of clinical immunoassay, 15(1), 1992, pp. 17-24
Risultati: 1-10 |